Although artificial intelligence in health has shown great promise, pressure is mounting for regulators around the world to act, as AI tools demonstrate potentially harmful outcomes.
Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
Cell and gene therapies represent an exciting and complex new treatment type, with the potential to treat a vast range of indications.
By
Maria Ressa built a successful media startup — and exposed human rights issues — while fighting disinformation and attacks from the Philippine government.
By
COVID-19 is upending data analytics practices, sidelining predictive analytics, and driving firms to external data and other economic indicators.
By
Workers need healthy challenge, complexity, and connection, automation expert Matt Beane argues in his book “The Skill Code.”
By
Investigative journalist Maria Ressa, a digital fellow at MIT, said the spread of disinformation on social media threatens democracies worldwide.
By
Improved handwashing habits at airports — even just a few — would curb the global spread of disease, new research finds.
By
Fighting misinformation, understanding powerful algorithms, and mitigating harms are top concerns for social media experts.
By
How will science and technology impact the human body, mind, and society in the 21st century? The inaugural Future of People conference will explore this increasingly important question.
